Cutler Group LP Galmed Pharmaceuticals Ltd. Transaction History

Cutler Group LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 09, 2019	SELL	$5.68 - $8.68 $1,704 - $2,604	-300 Reduced 75.0%	100 $0
Q1 2019 May 10, 2019	SELL	$7.27 - $9.07 $34,896 - $43,536	-4,800 Reduced 92.31%	400 $3,000
Q4 2018 Feb 05, 2019	SELL	$6.59 - $14.47 $1,977 - $4,341	-300 Reduced 5.45%	5,200 $35,000
Q3 2018 Nov 07, 2018	BUY	$10.55 - $15.28 $56,970 - $82,512	5,400 Added 5400.0%	5,500 $74,000
Q2 2018 Aug 10, 2018	BUY	$5.04 - $17.96 $504 - $1,796	100 New	100 $1,000

Ticker GLMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,088,400
Market Cap $122M
Description
Galmed Pharmaceuticals Ltd., a clinical-stage biopharmaceutical company, focuses on the development of therapeutics for the treatment of liver diseases. It develops Aramchol, an oral therapy, which is in Phase III study for the treatment of non-alcoholic steato-hepatitis (NASH) in patients with overweight or obesity and who are pre-diabetic or t...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.